- Joined
- Jul 3, 2024
- Messages
- 394
- Likes
- 181
Chinese Economy Watch
- Thread starter rockdog
- Start date
- Joined
- Jul 3, 2024
- Messages
- 394
- Likes
- 181
China's home-grown biotech firms unlock global potentials
(Xinhua) 09:37, December 14, 2024
A worker checks medicines at Shenyang Sinqi Pharmaceutical Co., Ltd. in Shenyang, northeast China's Liaoning Province, May 22, 2024. (Xinhua/Yang Qing)
SHANGHAI, Dec. 13 (Xinhua) -- Chinese biotech firms are emerging in a highly resource-intensive and time-consuming scientific innovation endeavor: drug discovery.
One of the latest examples was LaNova Medicines, a Shanghai-based biotech company, which secured a remarkable deal in November with its promising anticancer drug LM-299.
U.S. pharma giant Merck & Co., Inc., or MSD, obtained an exclusive global license to develop, manufacture and commercialize LaNova's clinical-stage novel investigational antibody, with a payment up to nearly 3.3 billion U.S. dollars.
"This agreement adds to MSD's growing oncology pipeline, and we look forward to advancing LM-299 with speed and rigor for patients in need," said Dean Y. Li, president of MSD Research Laboratories.
In the first half of 2024, China's innovative drug license-out deals reached 42 transactions, with the disclosed total transaction value increasing by 80 percent year on year.
Some companies have opted for the riskier path of going global on their own. In February 2022, Legend Biotech's Cilta-cel became the first Chinese CAR-T therapy to gain FDA approval in the United States for treating adult myeloma patients. It is priced at about 465,000 dollars per dose.
CAR-T is an immunotherapy involving the genetic engineering of a patient's T-cells to recognize and attack cancer cells.
BEST IN CLASS
The prospect of high profits draws Chinese biotech firms into the sector amid China's efforts to prioritize innovative drug discovery as a new economic engine. This year's government work report has highlighted it as an emerging industry alongside new energy vehicles, low-altitude economy, and commercial space, among others.
Competitiveness in the pharmaceutical industry hinges on securing core patents. Zanubrutinib, a cancer drug developed by Chinese biotech giant BeiGene, outperformed the U.S. blockbuster Ibrutinib in a "head-to-head" contest. Ibrutinib is the world's first BTK inhibitor, and it has been marketed and used for treating blood cancers.
The "head-to-head" clinical trial involves close combat where drug A challenges the established drug B to see which performs better. If A succeeds, it quickly rises to prominence; otherwise, it withdraws from the market.
Innovative drugs are typically classified as first-in-class, best-in-class, me-better, me-too, and me-worse. Until recently, China's pharmaceutical landscape was largely dominated by me-too and me-better drugs. Zanubrutinib is now a "best in class."
In 2023, Zanubrutinib achieved a total annual revenue of over 1 billion U.S. dollars for the first time.
UNMET DEMANDS
Chinese biotech entrepreneurs strategically focus on unmet medical needs to gain a foothold in international markets.
"Advanced colorectal cancer poses a significant medical challenge, with rising global incidence and mortality rates, and a dearth of effective new treatments," said Su Weiguo, CEO of Shanghai-based Hutchmed. "The United States has not seen a new drug approval in this field for 10 years."
In November last year, Hutchmed's fruquintinib received FDA approval for the treatment of metastatic colorectal cancer and was prescribed within 48 hours after the approval.
Junshi Biosciences, headquartered in Shanghai, made similar choices when exploring the U.S. market. "Our strategy is to prioritize the approval in the United States for nasopharyngeal carcinoma since it is a disease with unmet medical needs there," said Li Ning, CEO of Junshi Biosciences.
Overseas pharmaceutical titans are increasingly venturing into China for promising domestic biotech firms. AstraZeneca announced in February this year that it would establish its fifth global strategic center in Shanghai and support 30 Shanghai-based enterprises in their international expansion efforts.
FIRST IN CLASS
Some Chinese biotech firms are aiming high. They set their sights on groundbreaking first-in-class drugs with an ambition to lead in global innovation.
The first-in-class medication is a prototype drug that uses a "new and unique mechanism of action" to treat a particular medical condition.
So far, the number of approved China-designed first-in-class drugs has been few. Yet the landscape is on the cusp of transformation as an increasing number of home-grown players joined the game.
"China's 'low-hanging fruit' opportunities in drug discovery are dwindling, and only the more innovative first-in-class targets point to future prospects," said Chen Kan, co-founder of Qiming Venture Partners, which invests in new drug development.
Data from Pharmcube, a pharma consultancy, reveals that by August, China's new drug pipeline count stood at 5,380, representing over a third of the global total and nearly matching the United States.
Also, China ranks second globally in the number of first-in-class drug candidates poised to make debuts in the coming years.
Moreover, the rise of AI technology offers new possibilities for China's drug industry.
MindRank, a Hangzhou-based biotech firm, has harnessed AI drug discovery to develop a small molecule medication, MDR-001, targeting conditions such as obesity and type 2 diabetes.
This AI-driven approach enabled the research team to swiftly identify a preclinical candidate from nearly 100 molecules in just eight months. The drug candidate has now received clinical trial approvals in both China and the United States.
In 2023, XtalPi Inc., a Shanghai-based startup, introduced an AI-driven drug discovery solution that promises to overcome the speed limitations in chemical synthesis, enhance the success rate of drug development experiments, and reduce the development time for new drugs.
- Joined
- Jul 3, 2024
- Messages
- 851
- Likes
- 1,451
China’s poorly behaved aunties are at it again. A viral video shows a group of tourists from mainland China leaving a rental house in Osaka, Japan, in a complete mess after staying there for three days. The clip, shared on X by a Japanese blogger has been viewed 3.6 million times and sparked heated discussions among both Japanese and Chinese netizens.Join this channel to get access to perks:
View: https://www.youtube.com/watch?v=o6cqy7OFzX8
View: https://www.youtube.com/watch?v=o6cqy7OFzX8
- Joined
- Jul 3, 2024
- Messages
- 851
- Likes
- 1,451
okay
By Kevin Yao, Joe Cash and Ethan Wang
BEIJING (Reuters) - China's industrial output growth quickened slightly in November, while retail sales disappointed, keeping alive calls for Beijing to ramp up consumer-focused stimulus as policymakers brace for more U.S. trade tariffs under a second Trump administration.
The mixed data underline how challenging it will be for China's leaders to mount a durable economic recovery heading into 2025, when trade relations with China's biggest export market could worsen while domestic consumption also stays weak.
U.S. President-elect Donald Trump's vow to impose tariffs exceeding 60% on Chinese goods could push Beijing to accelerate plans to rebalance its $19 trillion economy, analysts said. This comes after over two decades of deliberation on transitioning from the current growth model focused on fixed-asset investment and exports to a consumption-driven one.
China's industrial output in November grew 5.4% from a year earlier, faster than the 5.3% pace seen in October, data from the National Bureau of Statistics (NBS) showed on Monday, beating expectations for a 5.3% increase in a Reuters poll.
However, retail sales, a gauge of consumption, grew at its weakest pace in three months at 3.0% last month, much slower than a 4.8% rise seen in October. Analysts had predicted a 4.6% expansion.
"China's economic policies have been amazingly consistent in promoting manufacturers over consumers despite clear signs of lasting weakness," said Dan Wang, a Shanghai-based independent economist.
"So, one can expect production capacity to strengthen, potentially agitating the overcapacity issue and motivating Chinese companies to seek overseas markets."
Fixed asset investment also increased at a slower 3.3% pace in January-November from the same period a year earlier, compared with an expected 3.4% rise. It grew 3.4% in the January to October period.
"Worries about the poor retail sales may be overdone, as it results from an early start of the 'Double 11' shopping festival which frontloaded sales to October," said Xu Tianchen, senior economist at the Economist Intelligence Unit.
"If we smooth the October-November data, then growth should average around 3.9%, which is higher than the previous months," he added. "But consumer demand is not strong in itself, it is still very reliant on government subsidies, which contributed about 1.5-2 percentage points to monthly retail sales."
POLICY SUPPORT PLEDGES
Policymakers have begun voicing their plans for 2025 in recent weeks, well aware of the fact that Trump's return to the White House will place considerable strain on an already ailing economy.
Over the weekend, an official at China's central bank said it had room to further cut the amount of cash banks must hold as reserves, but credit numbers out last week showed past easing had done little to boost borrowing.
That is partly because policymakers have yet to find a fix to a years-long property crisis that is dragging on consumer confidence, with some 70% of household savings parked in real estate.
And while there was some encouraging signs in China's new home prices, which fell at the slowest pace in 17 months in November, it remains too early to call a recovery, analysts say.
Stabilising the property sector, which at its peak constituted 25% of the economy, will be key if Beijing is to maintain a growth target of around 5% for next year, which Reuters has reported that policy advisers have recommended.
A recent Reuters poll predicted China will grow 4.5% next year, with new U.S. tariffs potentially shaving up to 1 parentage point off growth.
On Monday, Moody's Ratings raised China's GDP growth forecast to 4.2% from 4% for 2025.
At last week's Central Economic Work Conference (CEWC), a closely-watched agenda-setting meeting, China's top leaders pledged to raise the budget deficit, issue more debt, and make boosting consumption a top priority.
The remarks echoed commitments made by a meeting of top Communist Party officials, the Politburo, earlier this month, which endorsed an "appropriately loose" monetary policy in the first easing of its stance in 14 years.
"We think the deleration in November will probably prove temporary, with growth likely to pick up again over the coming months as policy support continues to be stepped up," said Julian Evans-Pritchard, head of China economics at Capital Economics.
"But we doubt that stimulus can deliver anything more than a short-lived improvement, not least because the current strength of export demand is unlikely to last once President Trump starts to put some of his tariff threats into action."
(Reporting by Kevin Yao, Joe Cash and Ethan Wang; Editing by Shri Navaratnam and Jacqueline Wong)
China's weak consumption drags on economy as Trump tariff threat looms
China's industrial output growth quickened slightly in November, while retail sales disappointed, keeping alive calls for Beijing to ramp up consumer-focused stimulus as policymakers brace for more U.S. trade tariffs under a second Trump administration. The mixed data underline how challenging...
DAMNokay
By Kevin Yao, Joe Cash and Ethan Wang
BEIJING (Reuters) - China's industrial output growth quickened slightly in November, while retail sales disappointed, keeping alive calls for Beijing to ramp up consumer-focused stimulus as policymakers brace for more U.S. trade tariffs under a second Trump administration.
The mixed data underline how challenging it will be for China's leaders to mount a durable economic recovery heading into 2025, when trade relations with China's biggest export market could worsen while domestic consumption also stays weak.
U.S. President-elect Donald Trump's vow to impose tariffs exceeding 60% on Chinese goods could push Beijing to accelerate plans to rebalance its $19 trillion economy, analysts said. This comes after over two decades of deliberation on transitioning from the current growth model focused on fixed-asset investment and exports to a consumption-driven one.
China's industrial output in November grew 5.4% from a year earlier, faster than the 5.3% pace seen in October, data from the National Bureau of Statistics (NBS) showed on Monday, beating expectations for a 5.3% increase in a Reuters poll.
However, retail sales, a gauge of consumption, grew at its weakest pace in three months at 3.0% last month, much slower than a 4.8% rise seen in October. Analysts had predicted a 4.6% expansion.
"China's economic policies have been amazingly consistent in promoting manufacturers over consumers despite clear signs of lasting weakness," said Dan Wang, a Shanghai-based independent economist.
"So, one can expect production capacity to strengthen, potentially agitating the overcapacity issue and motivating Chinese companies to seek overseas markets."
Fixed asset investment also increased at a slower 3.3% pace in January-November from the same period a year earlier, compared with an expected 3.4% rise. It grew 3.4% in the January to October period.
"Worries about the poor retail sales may be overdone, as it results from an early start of the 'Double 11' shopping festival which frontloaded sales to October," said Xu Tianchen, senior economist at the Economist Intelligence Unit.
"If we smooth the October-November data, then growth should average around 3.9%, which is higher than the previous months," he added. "But consumer demand is not strong in itself, it is still very reliant on government subsidies, which contributed about 1.5-2 percentage points to monthly retail sales."
POLICY SUPPORT PLEDGES
Policymakers have begun voicing their plans for 2025 in recent weeks, well aware of the fact that Trump's return to the White House will place considerable strain on an already ailing economy.
Over the weekend, an official at China's central bank said it had room to further cut the amount of cash banks must hold as reserves, but credit numbers out last week showed past easing had done little to boost borrowing.
That is partly because policymakers have yet to find a fix to a years-long property crisis that is dragging on consumer confidence, with some 70% of household savings parked in real estate.
And while there was some encouraging signs in China's new home prices, which fell at the slowest pace in 17 months in November, it remains too early to call a recovery, analysts say.
Stabilising the property sector, which at its peak constituted 25% of the economy, will be key if Beijing is to maintain a growth target of around 5% for next year, which Reuters has reported that policy advisers have recommended.
A recent Reuters poll predicted China will grow 4.5% next year, with new U.S. tariffs potentially shaving up to 1 parentage point off growth.
On Monday, Moody's Ratings raised China's GDP growth forecast to 4.2% from 4% for 2025.
At last week's Central Economic Work Conference (CEWC), a closely-watched agenda-setting meeting, China's top leaders pledged to raise the budget deficit, issue more debt, and make boosting consumption a top priority.
The remarks echoed commitments made by a meeting of top Communist Party officials, the Politburo, earlier this month, which endorsed an "appropriately loose" monetary policy in the first easing of its stance in 14 years.
"We think the deleration in November will probably prove temporary, with growth likely to pick up again over the coming months as policy support continues to be stepped up," said Julian Evans-Pritchard, head of China economics at Capital Economics.
"But we doubt that stimulus can deliver anything more than a short-lived improvement, not least because the current strength of export demand is unlikely to last once President Trump starts to put some of his tariff threats into action."
(Reporting by Kevin Yao, Joe Cash and Ethan Wang; Editing by Shri Navaratnam and Jacqueline Wong)
China's weak consumption drags on economy as Trump tariff threat looms
China's industrial output growth quickened slightly in November, while retail sales disappointed, keeping alive calls for Beijing to ramp up consumer-focused stimulus as policymakers brace for more U.S. trade tariffs under a second Trump administration. The mixed data underline how challenging...www.yahoo.com
how will you devalue yuan china bros..
world biggest shopping mall. My firm was subcontractor of its IT system.
View: https://youtu.be/tEaSDG_aB4w?si=PKTJ0wLhbvYBCa0M
View: https://youtu.be/tEaSDG_aB4w?si=PKTJ0wLhbvYBCa0M
- Joined
- Jul 3, 2024
- Messages
- 851
- Likes
- 1,451
A German-Canadian resident of China was sentenced to 24 months in prison in the U.S. for stealing electric vehicle trade secrets from Tesla for his competing EV battery business, the U.S. Department of Justice said on Monday.
Klaus Pflugbeil, 59, pleaded guilty in June to conspiring with business partner Yilong Shao to sell Tesla's battery manufacturing secrets to undercover FBI agents posing as Long Island businesspeople.
Pflugbeil's attorney and spokespeople for Tesla did not immediately respond to requests for comment on the sentencing. Shao, who was also charged but remains at large, could not be reached for comment.
"In stealing trade secrets from an American electric vehicle manufacturer to use in his own China-based company, Pflugbeil's actions stood to benefit the (People's Republic of China) in a critical industry with national security implications," U.S. Assistant Attorney General Matthew Olsen said in a statement.
Pflugbeil, who is a citizen of Germany and Canada, was charged in New York in March.
Prosecutors said he and Shao built their EV battery business on trade secrets from a "leading U.S.-based electric vehicle company." Prosecutors did not name the company, but said it acquired a Canada-based manufacturer of battery-assembly lines in 2019, which matches the description of Tesla's acquisition of Canadian company Hibar.
The Justice Department said Pflugbeil and Shao worked for the Canadian company before Pflugbeil joined Shao's business in 2020. Prosecutors said that Pflugbeil and Shao's venture has locations in China, Canada, Germany and Brazil that make the same battery assembly equipment as their previous employer.
Shao met the undercover agents at a trade show in Las Vegas last year, according to prosecutors, after which Pflugbeil sent them a business proposal containing Tesla's trade secrets.
(Reporting by Blake Brittain in Washington; Editing by Jamie Freed)
www.yahoo.com
Klaus Pflugbeil, 59, pleaded guilty in June to conspiring with business partner Yilong Shao to sell Tesla's battery manufacturing secrets to undercover FBI agents posing as Long Island businesspeople.
Pflugbeil's attorney and spokespeople for Tesla did not immediately respond to requests for comment on the sentencing. Shao, who was also charged but remains at large, could not be reached for comment.
"In stealing trade secrets from an American electric vehicle manufacturer to use in his own China-based company, Pflugbeil's actions stood to benefit the (People's Republic of China) in a critical industry with national security implications," U.S. Assistant Attorney General Matthew Olsen said in a statement.
Pflugbeil, who is a citizen of Germany and Canada, was charged in New York in March.
Prosecutors said he and Shao built their EV battery business on trade secrets from a "leading U.S.-based electric vehicle company." Prosecutors did not name the company, but said it acquired a Canada-based manufacturer of battery-assembly lines in 2019, which matches the description of Tesla's acquisition of Canadian company Hibar.
The Justice Department said Pflugbeil and Shao worked for the Canadian company before Pflugbeil joined Shao's business in 2020. Prosecutors said that Pflugbeil and Shao's venture has locations in China, Canada, Germany and Brazil that make the same battery assembly equipment as their previous employer.
Shao met the undercover agents at a trade show in Las Vegas last year, according to prosecutors, after which Pflugbeil sent them a business proposal containing Tesla's trade secrets.
(Reporting by Blake Brittain in Washington; Editing by Jamie Freed)
China resident who stole Tesla trade secrets gets 2-year US sentence
A German-Canadian resident of China was sentenced to 24 months in prison in the U.S. for stealing electric vehicle trade secrets from Tesla for his competing EV battery business, the U.S. Department of Justice said on Monday. Klaus Pflugbeil, 59, pleaded guilty in June to conspiring with...
www.yahoo.com
- Joined
- Jul 3, 2024
- Messages
- 851
- Likes
- 1,451
Chinese EVs are gaining traction worldwide, and Ford isn’t waiting for a battle on the home front to have an answer. Jim Farley, CEO of Ford, vows that the next EV that comes out of Dearborn will be a “game-changing” new mid-size electric pickup truck. Farley claims the truck will closely rival Chinese competitors, specifically in terms of production costs. Of course, there is one small problem: the truck is still three years away from hitting the market.
Related: EV battery prices are plunging
Ford needs to drive EV profits and Chinese automakers are squarely in their sights
With billions of dollars in EV losses through the first half of 2024, Ford needs to step it up when it comes to profitability. Farley claims that Ford will “match the cost structure of any Chinese manufacturer building in Mexico in the future.”
How can he be so sure, you ask? He followed that up by stating that “60 percent of the [bill of materials] has already been quoted.” So, Ford knows exactly how much it should cost to put together the new truck when the time finally comes. And, more importantly, that it can, in fact, be profitable.
The new mid-size electric truck is anticipated to compete directly with trucks like the BYD Shark, which is available for pre-orders in global markets. Cost-saving methods include in-house battery assembly and relying on a flexible platform shared across models.
Earlier this year, Farley praised the Skunkworks team working on a platform that is slated to be shared with many electrified Ford vehicles coming in the near-to-distant future, claiming that they’ve “over-delivered.” With a chassis that good and the added bonus of LFP battery production beginning in Michigan sometime in 2026, the outlook admittedly looks good. But, that brings us to the problem of timing.
Delays have pushed the Ford truck’s production back considerably
Ford has changed its EV plans more than a few times. Between scrapping a three-row electric SUV and diversifying hybrid offerings, the landscape looks very different today than it did even just a few months ago. The truck, thus far only known as “Project T3,” isn’t slated to hit the market until late 2027, and Ford hasn’t released any further information on the truck.
Despite the considerable delay, Ford still plans to rely on their Tennessee factory to assemble the truck. Meanwhile, BYD is considering a production site in Mexico that will tout a reported 150,000 units of annual capacity.
Seeing as how Mexico has already started taking delivery of BYD vehicles – and the Shark makes landfall globally early next year – we can’t help but feel Ford is a little bit behind the times. In most markets, the BYD Shark is priced around the equivalent of $55,000 and squarely competes with the existing Ford Ranger and Toyota Hilux.
Related: Mazda Iconic SP inches closer to production — CEO confirms
Final thoughts
Ford needs to make a profitable EV. Everyone knows it, and nobody better than Farley and Ford themselves. The EV marketplace is full of automakers brandishing promises like magic wands. It’s simply too early to tell how relevant a mid-size Ford EV truck will fare in the grand scheme of things, particularly one that's three or more years away from the market. We like what we hear so far – we just hope it’s enough to keep Ford in the game
www.yahoo.com
Related: EV battery prices are plunging
Ford needs to drive EV profits and Chinese automakers are squarely in their sights
With billions of dollars in EV losses through the first half of 2024, Ford needs to step it up when it comes to profitability. Farley claims that Ford will “match the cost structure of any Chinese manufacturer building in Mexico in the future.”
How can he be so sure, you ask? He followed that up by stating that “60 percent of the [bill of materials] has already been quoted.” So, Ford knows exactly how much it should cost to put together the new truck when the time finally comes. And, more importantly, that it can, in fact, be profitable.
The new mid-size electric truck is anticipated to compete directly with trucks like the BYD Shark, which is available for pre-orders in global markets. Cost-saving methods include in-house battery assembly and relying on a flexible platform shared across models.
Earlier this year, Farley praised the Skunkworks team working on a platform that is slated to be shared with many electrified Ford vehicles coming in the near-to-distant future, claiming that they’ve “over-delivered.” With a chassis that good and the added bonus of LFP battery production beginning in Michigan sometime in 2026, the outlook admittedly looks good. But, that brings us to the problem of timing.
Delays have pushed the Ford truck’s production back considerably
Ford has changed its EV plans more than a few times. Between scrapping a three-row electric SUV and diversifying hybrid offerings, the landscape looks very different today than it did even just a few months ago. The truck, thus far only known as “Project T3,” isn’t slated to hit the market until late 2027, and Ford hasn’t released any further information on the truck.
Despite the considerable delay, Ford still plans to rely on their Tennessee factory to assemble the truck. Meanwhile, BYD is considering a production site in Mexico that will tout a reported 150,000 units of annual capacity.
Seeing as how Mexico has already started taking delivery of BYD vehicles – and the Shark makes landfall globally early next year – we can’t help but feel Ford is a little bit behind the times. In most markets, the BYD Shark is priced around the equivalent of $55,000 and squarely competes with the existing Ford Ranger and Toyota Hilux.
Related: Mazda Iconic SP inches closer to production — CEO confirms
Final thoughts
Ford needs to make a profitable EV. Everyone knows it, and nobody better than Farley and Ford themselves. The EV marketplace is full of automakers brandishing promises like magic wands. It’s simply too early to tell how relevant a mid-size Ford EV truck will fare in the grand scheme of things, particularly one that's three or more years away from the market. We like what we hear so far – we just hope it’s enough to keep Ford in the game
Ford CEO says new mid-size electric pickup will match the cost of Chinese EVs
Farley targets Chinese automakers like BYD in a race to the bottom - price, that is.
- Joined
- Jul 1, 2024
- Messages
- 1,013
- Likes
- 2,286
What the US & European car manufacturers aside from Tesla needs to understand is that the Chinese are becoming masters of the IDIOT index of EV vehicles and US & European are not. This is the first thing they need to realize that otherwise their efforts are just a waste of time and money. They might as well throw in the towel.
- Joined
- Jul 3, 2024
- Messages
- 851
- Likes
- 1,451
Ford turbocharges electric car manufacturing, announces $273 million investment in Guanajuato
Sep 01, 2024 Automotive Test, More Industry Comments Off
Now called IEPC, Irapuato Electric Powertrain Center, (by its name in English), this plant supports the production of Cuautitlán Izcalli, as it is responsible for manufacturing Primary Drive Units for the manufacture of Mustang Mach-E, the first 100% electric mass-produced vehicle made in Mexico and for export to 41 countries in America, Europe and Australia.
www.vanguardia-industrial.net
With new low-cost Chinese flooding global markets, Ford CEO Jim Farley vows its new mid-size electric pickup is a “game changer.” Ford’s leader took a jab at BYD, vowing the company’s new electric pickup will match the costs of Chinese automakers building in Mexico.
electrek.co
View: https://www.youtube.com/watch?v=A5Avljkwbzg
View: https://www.youtube.com/watch?v=OA7p3nw5Bts
Sep 01, 2024 Automotive Test, More Industry Comments Off
Now called IEPC, Irapuato Electric Powertrain Center, (by its name in English), this plant supports the production of Cuautitlán Izcalli, as it is responsible for manufacturing Primary Drive Units for the manufacture of Mustang Mach-E, the first 100% electric mass-produced vehicle made in Mexico and for export to 41 countries in America, Europe and Australia.
Ford mete turbo a la fabricación de autos eléctricos, anuncia inversión de 273 mdd en Guanajuato – Vanguardia Industrial
www.vanguardia-industrial.net
With new low-cost Chinese flooding global markets, Ford CEO Jim Farley vows its new mid-size electric pickup is a “game changer.” Ford’s leader took a jab at BYD, vowing the company’s new electric pickup will match the costs of Chinese automakers building in Mexico.
Ford CEO says new mid-size electric pickup will match the cost of Chinese EVs like BYD
With new low-cost Chinese flooding global markets, Ford CEO Jim Farley vows its new mid-size electric pickup is a “game...
electrek.co
View: https://www.youtube.com/watch?v=A5Avljkwbzg
View: https://www.youtube.com/watch?v=OA7p3nw5Bts
chinabros what the actual fuk is going on here. i thought china would japanify but i didnt see it happening at this pace.
this is looks like depression..
dont collapse yet chinabros we need you to keep the great satan occupied for a few more years. (i'm not trolling - dont collapse yet)
this is looks like depression..
dont collapse yet chinabros we need you to keep the great satan occupied for a few more years. (i'm not trolling - dont collapse yet)
- Joined
- Jul 3, 2024
- Messages
- 394
- Likes
- 181
Indiabros, you were right,
The Chinese economy often collapses several times a month at the DFB
- Joined
- Jul 3, 2024
- Messages
- 851
- Likes
- 1,451
maybe not collapse but definitively many nations are putting tariffs
NEW DELHI (Reuters) - India is likely to impose a "safeguard duty" or temporary tax of up to 25% on steel imports, industry and government sources said, to help to curb cheap imports from top producer China.
The proposal gained broad support at a meeting chaired by commerce minister Piyush Goyal on Tuesday after small industries dropped initial opposition once they received assurances that they would not be hit by higher steel prices.
"It seems the safeguard duty will be imposed after an investigation, likely completed within a month," said an industry official who attended the meeting. "To address concerns of small manufacturers, large steelmakers will supply them steel at reduced prices."
Brazil imposes new tariffs on Chinese imports
Despite the significant policy change, analysts suggest that a strong reaction from China is unlikely, highlighting the complex interplay between economic strategy and diplomatic relations.
Brazil imposes new tariffs on Chinese imports | Digital Watch Observatory
Despite the significant policy change, analysts suggest that a strong reaction from China is unlikely, highlighting the complex interplay between economic strategy and diplomatic relations.
dig.watch
maybe not collapse but definitively many nations are putting tariffs
NEW DELHI (Reuters) - India is likely to impose a "safeguard duty" or temporary tax of up to 25% on steel imports, industry and government sources said, to help to curb cheap imports from top producer China.
The proposal gained broad support at a meeting chaired by commerce minister Piyush Goyal on Tuesday after small industries dropped initial opposition once they received assurances that they would not be hit by higher steel prices.
"It seems the safeguard duty will be imposed after an investigation, likely completed within a month," said an industry official who attended the meeting. "To address concerns of small manufacturers, large steelmakers will supply them steel at reduced prices."
Brazil imposes new tariffs on Chinese imports
Despite the significant policy change, analysts suggest that a strong reaction from China is unlikely, highlighting the complex interplay between economic strategy and diplomatic relations.
Brazil imposes new tariffs on Chinese imports | Digital Watch Observatory
Despite the significant policy change, analysts suggest that a strong reaction from China is unlikely, highlighting the complex interplay between economic strategy and diplomatic relations.
Donald Trump’s tariff plans turn Chinese investment in Mexico into a waiting game
Trump’s tariff plans turn Chinese investment in Mexico into a waiting game
US president-elect on Monday said his new administration would immediately impose a 25 per cent tariff on imports from Mexico.
www.scmp.com
China’s BYD pauses Mexico factory plans until after US election
China’s BYD pauses Mexico factory plans until after US election
Mexico could be a key production site for BYD, along with plants it is building or already operating in Brazil, Hungary, Turkey and Thailand.
www.scmp.com
- Joined
- Jul 3, 2024
- Messages
- 394
- Likes
- 181
Similar threads
Latest Replies
-
Jokes Thread- haldilal
-
Failed Terrorist State of Pakistan: Idiotic Musings- The Juggernaut
-
DRDO and PSU's- ezsasa
-
Pakistan Economy- FalconSlayers
-
Indian Navy Developments & Discussions
- Ayan Barat
-
LVM3/GSLV MkIII Rocket - News, updates and reports- Indx TechStyle
-
Indian Culture and society
- haldilal
-
AMCA - Advanced Medium Combat Aircraft
- Bhartiya Sainik
Trending Threads
Share this Site
